Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.
about
Oral pathology in inflammatory bowel diseaseSusceptibility of Pneumocystis to echinocandins in suspension and biofilm culturesImmune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia.Analogs of pentamidine as potential anti-Pneumocystis chemotherapeutics.Type 1 interferons suppress accelerated osteoclastogenesis and prevent loss of bone mass during systemic inflammatory responses to Pneumocystis lung infection.Increased dosage of infliximab is a potential cause of Pneumocystis carinii pneumonia.Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel diseaseProphylaxis for Pneumocystis pneumonia in patients with rheumatoid arthritis treated with biologics, based on risk factors found in a retrospective study.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Pneumocystis pneumonia complicating immunosuppressive therapy in Crohns disease: A preventable problem?Pneumocystis jirovecii Pneumonia in Pediatric Inflammatory Bowel Disease: A Case Report and Literature Review.Low Risk of Pneumonia From Pneumocystis jirovecii Infection in Patients With Inflammatory Bowel Disease Receiving Immune Suppression.
P2860
Q26739055-CA9A5D08-3A6B-4FA5-80A5-9A41EE1C8BD7Q28477349-0073F76C-CC39-4878-987F-A927AC8AAF38Q33680480-B4BB08C7-5B08-4E10-82E3-1746201702A7Q35740410-D49A5E5D-9D4E-4EB9-8B9F-00352D622D18Q36071793-D2ED54A7-260A-44E4-8FFE-3B74420A8189Q36530539-1B244D20-4D7C-4DF7-BF8C-C578F42CC3CFQ37429242-B3CFE4F7-9593-4139-B0AC-F13BE31CFAC8Q37690719-49EC12E6-4E2F-4F7D-925D-807050622A9CQ37814549-600A3F65-2C1D-44A3-8FFB-048C215C3C64Q40080089-8603CFEE-E0FA-4D4F-BA35-05035A1BC1D4Q40100993-454E3925-CCF1-4D42-839E-72FEF5EEBDCAQ40396288-64BB75D0-872D-4BB5-B076-64B8BEBB4BED
P2860
Pneumocystis carinii pneumonia with oral candidiasis after infliximab therapy for Crohn's disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@ast
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@en
type
label
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@ast
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@en
prefLabel
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@ast
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@en
P1476
Pneumocystis carinii pneumonia ...... b therapy for Crohn's disease.
@en
P2093
Nirmal Kaur
Thomas C Mahl
P304
P356
10.1023/B:DDAS.0000042246.58984.98
P577
2004-09-01T00:00:00Z
P6179
1025890792